475 related articles for article (PubMed ID: 27888990)
1. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
[TBL] [Abstract][Full Text] [Related]
2. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD.
Sun X; He Z; Zhang J; Deng J; Bai J; Li M; Zhong X
Pulm Pharmacol Ther; 2015 Apr; 31():111-6. PubMed ID: 25281894
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
[TBL] [Abstract][Full Text] [Related]
4. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis.
Zheng JP; Zhang J; Ma LJ; Chen P; Huang M; Ou XM; Zhao ZW; Jiang SJ; Cao J; Yao W
Int J Chron Obstruct Pulmon Dis; 2019; 14():2725-2731. PubMed ID: 31819404
[TBL] [Abstract][Full Text] [Related]
6. Nebulized Corticosteroids in the Treatment of COPD Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective.
Pleasants RA; Wang T; Xu X; Beiko T; Bei H; Zhai S; Drummond MB
Respir Care; 2018 Oct; 63(10):1302-1310. PubMed ID: 30237276
[TBL] [Abstract][Full Text] [Related]
7. The effect of ventilator mask atomization inhalation of ipratropium bromide and budesonide suspension liquid in the treatment of COPD in acute exacerbation period on circulating levels of inflammation and prognosis.
Jiang DH; Wang X; Liu LS; Ji DD; Zhang N
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5211-5216. PubMed ID: 29228436
[TBL] [Abstract][Full Text] [Related]
8. [Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules].
Makarova EV; Varvarina GN; Menkov NV; Czapaeva MY; Lazareva ES; Kazatskaya ZA; Novikov VV; Karaulov AV
Ter Arkh; 2016; 88(3):24-31. PubMed ID: 27030325
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
Maltais F; Ostinelli J; Bourbeau J; Tonnel AB; Jacquemet N; Haddon J; Rouleau M; Boukhana M; Martinot JB; Duroux P
Am J Respir Crit Care Med; 2002 Mar; 165(5):698-703. PubMed ID: 11874817
[TBL] [Abstract][Full Text] [Related]
10. Heliox as a driving gas to atomize inhaled drugs on acute exacerbation of chronic obstructive pulmonary disease: a prospective clinical study.
Xiao Y; Su L; Han B; Zhang X; Xie L
Chin Med J (Engl); 2014; 127(1):29-35. PubMed ID: 24384420
[TBL] [Abstract][Full Text] [Related]
11. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
Cazzola M
Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
[TBL] [Abstract][Full Text] [Related]
12. Inhaled and intravenous corticosteroids both attenuate chlorine gas-induced lung injury in pigs.
Wang J; Winskog C; Edston E; Walther SM
Acta Anaesthesiol Scand; 2005 Feb; 49(2):183-90. PubMed ID: 15715619
[TBL] [Abstract][Full Text] [Related]
13. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of two corticosteroid regimens in acute exacerbation of chronic obstructive pulmonary disease.
Aggarwal P; Wig N; Bhoi S
Int J Tuberc Lung Dis; 2011 May; 15(5):687-92. PubMed ID: 21756523
[TBL] [Abstract][Full Text] [Related]
15. A score to predict short-term risk of COPD exacerbations (SCOPEX).
Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
17. Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.
Cazzola M; Noschese P; De Michele F; D'Amato G; Matera MG
Respir Med; 2006 Feb; 100(2):212-7. PubMed ID: 15936184
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacies of nebulized budesonide and systemic corticosteroids in the treatment of exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Gu YL; Pang J; Sun ZX; Hu J; Sun Y; Wu XW; Guo JJ; Yang GS
J Clin Pharm Ther; 2020 Jun; 45(3):419-429. PubMed ID: 31954070
[TBL] [Abstract][Full Text] [Related]
19. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.
Zhang J; Zheng J; Huang K; Chen Y; Yang J; Yao W
Ther Adv Respir Dis; 2018; 12():1753466618769514. PubMed ID: 29692212
[TBL] [Abstract][Full Text] [Related]
20. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
Magnussen H; Watz H; Kirsten A; Decramer M; Dahl R; Calverley PM; Towse L; Finnigan H; Tetzlaff K; Disse B
Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
